此平台股东为被执行人
此平台股东为被执行人，欠员工薪资，可以视为没有契约精神，望周知
掌上微试 - 让临床研究更简单
Published by:
Beijing CTSLtd
Description
掌上微试是微试平台（www.WeTrial.com）开发的移动端应用，提供给微试平台的临床试验机构、临床试验伦理、临床试验申办方、CRO公司使用的一款临床试验项目管理移动工具，通过掌上微试随时随地进行项目文档管理，在线查阅项目文档，拍照上传（自动转换为PDF格式），实现项目文档的高效、方便快捷地归档和共享；查看临床项目概要，方案摘要，项目进度，入组统计，SAE；消息提醒；个人ID信息。
掌上微试把WeTrial平台临床试验各方（申办方、临床机构、科室、伦理、受试者等）连接起来，大家在一个共同信息平台内协同工作，实现临床试验项目管理、质量控制、沟通、共享的联动效应，促使整个临床试验更加高效。
Hide
Show More...
掌上微试把WeTrial平台临床试验各方（申办方、临床机构、科室、伦理、受试者等）连接起来，大家在一个共同信息平台内协同工作，实现临床试验项目管理、质量控制、沟通、共享的联动效应，促使整个临床试验更加高效。
Screenshots
掌上微试 FAQ
-
Is 掌上微试 free?
Yes, 掌上微试 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 掌上微试 legit?
🤔 The 掌上微试 app's quality is mixed. Some users are satisfied, while others report issues. Consider reading individual reviews for more context.
Thanks for the vote -
How much does 掌上微试 cost?
掌上微试 is free.
-
What is 掌上微试 revenue?
To get estimated revenue of 掌上微试 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Argentina yet.
Ratings History
掌上微试 Reviews
日期不能显示
换了手机后，录工时的时候日期不显示出来，盲滑，能解决一下不？
打不开
打开页面时一直是白板，无法查看项目等信息
方便实用
确实很实用，部门项目全线启用该系统，项目进展、质量一目了然，怎么发不出去啦啦啦
我是一枚CRC
我是CRC，录入起来很方便，界面简洁清楚，唯一不足的是重复的任务很多，增加工作量，工时很贵的！
通过这个平台来管理临床试验的项目，非常方便，也清楚自己每天该干些什么事情
越来越好用了
推荐
应该是临床试验行业最好用的App了
pm的好工具
进度管理太好了！ 从计划、任务拆解、分配、跟踪管理、沟通互动、文档跟踪。 界面希望再优化一下就更好了。
差评！！！
体验太差。
好用
临床试验的APP好用啊
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
掌上微试 Installs
Last 30 days
掌上微试 Revenue
Last 30 days掌上微试 Revenue and Downloads
Gain valuable insights into 掌上微试 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Beijing CTSLtd
- Languages
- Chinese
- Recent release
- 5.31.0 (2 weeks ago )
- Released on
- Sep 14, 2015 (9 years ago )
- Also available in
- China , Portugal , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , Poland , India , Romania , Russia , Saudi Arabia , Sweden , Singapore , Slovakia , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , Italy , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel , United Arab Emirates
- Last Updated
- 5 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.